Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Long-term clinical evidence of comparable efficacy and toxicity of nivolumab and pembrolizumab in advanced melanoma treatmentMelanoma Res. 2023 Jun 01;33(3)208-217, B Cybulska-Stopa, K Piejko, K Ostaszewski, R Dziura, Ł Galus, B Ziółkowska, N Kempa-Kamińska, M Ziętek, W Bal, A Kamycka, M Dudzisz-Śledź, T Kubiatowski, G Kamińska-Winciorek, R Suwiński, J Mackiewicz, AM Czarnecka, P Rutkowski
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.